|
2024
|
P/S
|
Biological preparations for the treatment of endothelial diseases and disorders, renal diseases, ... |
|
|
Invention
|
Pde 7 modulator compounds.
Compounds having activity as modulators of phosphodiesterase 7 (PDE 7... |
|
|
Invention
|
Pde 7 modulator compounds. Compounds having activity as modulators of phosphodiesterase 7 (PDE 7)... |
|
|
P/S
|
Biochemical preparations for medical purposes, namely, for the treatment of endothelial diseases ... |
|
|
Invention
|
Methods for inhibiting fibrosis in a subject in need thereof.
In one aspect, the invention provi... |
|
|
Invention
|
Masp-2 inhibitors and methods of use.
The present disclosure provides, inter alia, compounds wit... |
|
|
P/S
|
Biological and pharmaceutical preparations for the treatment of transplant complications, ischemi... |
|
|
P/S
|
Pharmaceutical preparations for complement-mediated diseases, addiction and oncology, none of the... |
|
|
Invention
|
Methods for treating conditions associated with masp-2 dependent complement activation.
In one a... |
|
|
Invention
|
Methods for inhibiting angiogenesis in a subject in need thereof.
In one aspect, the present inv... |
|
|
P/S
|
Biochemical preparations for medical purposes, namely, for
the treatment of endothelial diseases... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of endothelial
diseases and disorders, renal disea... |
|
|
P/S
|
Pharmaceutical preparations for complement-mediated diseases, addiction and oncology |
|
|
P/S
|
Medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals, ... |
|
|
Invention
|
Methods for treating and/or preventing idiopathic pneumonia syndrome (ips) and/or capillary leak... |
|
2023
|
Invention
|
Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrha... |
|
|
Invention
|
Antibodies specifically binding to masp-3 for the treatment of various diseases and disorders.
T... |
|
|
Invention
|
Masp-2 inhibitors and methods of use.
The disclosure provides synthetic compositions useful as i... |
|
|
Invention
|
Fused pyrimidines as masp-2 inhibitors. The disclosure provides synthetic compositions useful as ... |
|
|
Invention
|
Therapeutic methods and uses for antibodies to human masp-3.
Methods of treating paroxysmal noct... |
|
|
Invention
|
Therapeutic methods and uses for antibodies to human masp-3. Methods of treating paroxysmal noctu... |
|
|
Invention
|
Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods of t... |
|
|
Invention
|
Compositions and methods of inhibiting masp-1 and/or masp-2 and/or masp-3 for the treatment of va... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of endothelial diseases and disorders, renal diseas... |
|
|
Invention
|
Methods and compositions for treating cancer.
This disclosure is directed to compounds, composit... |
|
|
Invention
|
Therapeutic antibodies that bind to the serine protease domain of masp-2 and uses thereof. Isolat... |
|
|
P/S
|
Medical and scientific research information in the field of
pharmaceuticals, biopharmaceuticals,... |
|
|
P/S
|
Biological and pharmaceutical preparations for the treatment
of transplant complications, ischem... |
|
|
Invention
|
Masp-2 and masp-3 inhibitors, and related compositions and methods, for treatment of sickle cell ... |
|
|
Invention
|
Highly concentrated low viscosity masp-2 inhibitory antibody formulations, kits, and methods.
Th... |
|
|
Invention
|
Compositions for inhibiting masp-2 dependent complement activation.
The present invention relate... |
|
2022
|
Invention
|
Therapeutic antibodies that bind to the serine protease domain of masp-2 and uses thereof.
Isola... |
|
|
Invention
|
Masp-2 inhibitors and methods of use. The present disclosure provides, inter alia, compounds with... |
|
|
P/S
|
Providing information concerning medical and scientific research with respect to transplant compl... |
|
|
Invention
|
Compositions and methods of inhibiting masp-2 for the treatment of various thrombotic diseases an... |
|
|
Invention
|
Inhibitors of gpr174 and uses thereof.
GPR174 is an orphan receptor that has been implicated in ... |
|
|
Invention
|
Targeted catalytic complement-activating molecules and methods of use thereof.
In one aspect, th... |
|
|
Invention
|
Targeted catalytic complement-activating molecules and methods of use thereof. In one aspect, the... |
|
|
Invention
|
Methods and compositions for treating cancer.
Compounds, compositions, and methods for generatin... |
|
|
Invention
|
Methods and compositions for treating cancer. Compounds, compositions, and methods for generating... |
|
|
P/S
|
Providing medical and scientific research information in the
fields of pharmaceuticals and bioph... |
|
|
P/S
|
Providing medical and scientific research information in the fields of pharmaceuticals and biopha... |
|
|
Invention
|
Treatment of addiction and impulse-control disorders using pde7 inhibitors.
This disclosure is d... |
|
|
Invention
|
Chimeric inhibitor molecules of complement activation. The present invention relates to novel chi... |
|
|
P/S
|
Printed publications in the nature of brochures, pamphlets, newsletters, written articles and gui... |
|
|
P/S
|
Medical information services, namely, providing information concerning pharmaceutical and biophar... |
|
|
Invention
|
Biomarker for assessing the risk of developing acute covid-19 and post-acute covid-19.
Disclosed... |
|
|
Invention
|
Biomarker for assessing the risk of developing acute covid-19 and post-acute covid-19. Disclosed ... |
|
2021
|
Invention
|
Compositions and methods of inhibiting masp-1 and/or masp-2 and/or masp-3 for the treatment of pa... |
|
2020
|
P/S
|
Research and development in the pharmaceutical and biotechnology fields; providing medical and sc... |
|
2019
|
P/S
|
Pharmaceuticals and pharmaceutical preparations; biologics. |
|
|
P/S
|
Pharmaceutical preparations containing pharmacologic agents
for the inhibition of pain, inflamma... |
